内甲素受体对抗剂在病中的作用
Xiaoting Ma1, Yuyang Liang1, Wenmin Chen1
1Department of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, Shantou, China.
Renal failure
|February 27, 2025
概括
内甲素受体对抗剂 (ERA) 通过减少蛋白尿和改善膜过率 (GFR) 来治疗脏疾病具有前景. 这些疗法针对慢性脏病等疾病中内甲素 (ET) 的有害影响.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 心血管研究研究心血管研究
背景情况:
- 病影响全球超过8.5亿人,包括急性损伤和慢性病.
- 内分泌素 (ET) 在病的发病和进展中起着至关重要的作用.
- 病理状况提升ET,激活内甲蛋白受体A型,导致蛋白尿和减少膜过率 (GFR).
研究的目的:
- 在治疗病时审查内甲素受体抗剂 (ERA) 的作用机制.
- 在临床前和临床研究中评估ERA的疗效和安全性.
- 探索ERA在治疗脏疾病方面的未来前景.
主要方法:
- 对内甲素受体抗剂 (ERA) 的临床前和临床研究的综述.
- 分析ERA对蛋白尿和膜过率 (GFR) 的影响.
- 讨论内甲蛋白 (ET) 在病发病过程中的作用.
主要成果:
- 内甲素受体对抗剂 (ERA) 在减少蛋白尿症方面表现出显著的有效性.
- ERAs已经显示出改善膜过率 (GFR) 的潜力,从而减缓疾病的进展.
- 研究证实了内甲素 (ET) 升高与病态病症之间的联系.
结论:
- 内甲素受体抗剂 (ERA) 是一种有前途的治疗策略,可以减缓脏疾病的进展.
- ERAs有效地减轻内分泌素 (ET) 对功能的不良影响.
- 对ERA的进一步研究有可能改善慢性病和急性损伤的管理.
相关概念视频
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
123
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
123
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
447
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
447
01:25Antihypertensive Drugs: Direct Renin Inhibitors
468
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
468
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
568
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
568
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K